✦ LIBER ✦

Cognitive impairment as a target for pharmacological treatment in schizophrenia

✍ Scribed by Davidson, Michael; Keefe, Richard S.E.

Book ID: 123323467
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 597 KB
Volume: 17
Category: Article
ISSN: 0920-9964
DOI: 10.1016/0920-9964(95)00037-M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

IS COGNITIVE IMPAIRMENT IN SCHIZOPHRENIA

IS COGNITIVE IMPAIRMENT IN SCHIZOPHRENIA A REALISTIC TARGET FOR PHARMACOLOGICAL INTERVENTION?

✍ Michael Davidson 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Cognitive deficits as treatment targets

Cognitive deficits as treatment targets in schizophrenia

✍ James M. Gold 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Developing treatments for impaired cogni

Developing treatments for impaired cognition in schizophrenia

✍ Michael J. Minzenberg; Cameron S. Carter 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 167 KB

OLIGODENDROCYTES AS A TARGET FOR TREATME

OLIGODENDROCYTES AS A TARGET FOR TREATMENT IN SCHIZOPHRENIA

✍ Steiner, Johann; Uranova, Natalya; Schmitt, Andrea 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 91 KB

[Handbook of Experimental Pharmacology]

[Handbook of Experimental Pharmacology] Novel Antischizophrenia Treatments Volume 213 || Cognitive Impairment in Schizophrenia

✍ Geyer, Mark A.; Gross, Gerhard 📂 Article 📅 2012 🏛 Springer Berlin Heidelberg ⚖ 277 KB

Cognitive impairment in late life schizo

Cognitive impairment in late life schizophrenia: a suitable case for treatment?

✍ Robert Howard 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

The benign side-effect profiles of the atypical antipsychotic drugs have earned them an important niche in old age psychiatry. Evidence for a specific improvement in cognitive function associated with the use of these drugs is inconsistent and the definitive studies are still awaited. If these drugs